Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 3-kinase (PI3K) regulatory subunit gamma is a component of the PI3K enzyme complex, which plays a central role in cell signaling pathways that regulate growth, survival, proliferation, motility, and immune responses. It is part of class IB PI3Kγ, existing as heterodimers composed of a p110γ catalytic subunit paired with either a p101 or p87 (also known as p84) non-catalytic regulatory subunit. These non-catalytic subunits determine the specificity and regulation of PI3Kγ activity in response to upstream signals. PI3Kγ is primarily involved in linking GPCR activation to downstream production of phosphatidylinositol 3,4,5-trisphosphate (PIP₃), regulating leukocyte chemotaxis, modulating immune cell functions, and acting as a scaffold for protein kinase A (PKA) complexes. Dysregulation or mutation can contribute to inflammatory diseases or cancer progression.
PI3Kγ inhibitors block the PI3K signaling pathway, reducing PIP3 production and downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3-kinase Regulatory Subunit Gamma (PI3Kγ regulatory subunit).